AndhraNews.net
Home » Features » Health » Alzheimer's Disease

Alzheimer's Disease


Alzheimer's disease (AD) is the most common form of dementia. There is no cure for the disease, which worsens as it progresses, and eventually leads to death. It was first described by German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after him.

Studies

In May 2012, a phase II clinical trial is in progress to examine the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease. The compound Resveratrol is found in red grapes, red grape juice, red wine, chocolate, tomatoes and peanuts.

Alzheimer's Disease in News

GNT Pharma's Ropesalazine Effective in Treating Dog Dementia
Business Wire India New translational paradigm for Alzheimer’s disease World’s first neuroprotection drug for dog dementia

Cerveau Technologies, Inc. Signs Research Agreement with Tokyo Metropolitan Institute of Gerontology, Japan
Business Wire IndiaCerveau Technologies Inc. today announced an agreement with the Tokyo Metropolitan Institute of Gerontology in Japan to support multiple projects over the next several years

Boehringer Ingelheim R&D Pushes to Transcend Disease Boundaries
Business Wire IndiaPromising first-in-class and potential medical breakthrough pipeline projects presented at R&D Press Conference

Morinaga Milk's New Probiotic Strain, Bifidobacterium breve A1, May Prevent Onset of Alzheimer's Disease
Business Wire IndiaMorinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, announced the results of a new study investigating the preventive effects of its new probiotic strain Bifidobacterium breve A1 on a model of Alzheimer’s disease. Researchers found that B

Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage
Business Wire India Excessive bleeding after childbirth (postpartum haemorrhage or PPH) is the leading direct cause of maternal mortality worldwide1 The CHAMPION trial is assessing the effectiveness and safety of heat-stable carbetocin vs. oxytocin, the current standard of care, for preventing PPH after vaginal birth2,3​

CTD Holdings Finalizes Cooperative Agreement for Alzheimer's Disease Research Program
ALACHUA, FL--(Marketwired - April 19, 2018) - CTD Holdings, Inc

ORYZON receives approval to start ETHERAL: a Phase IIa clinical trial in Alzheimer's Disease with ORY-2001

CTD Holdings Announces FDA Authorization to Proceed with Single Patient IND for Use of Trappsol(R) Cyclo(TM) to Treat Alzheimer's Disease
ALACHUA, FL--(Marketwired - March 12, 2018) - CTD Holdings, Inc

Cantabio Pharmaceuticals to Present Results from its Tau Protein Targeting Therapeutic Program for the treatment of Alzheimer's Disease at the Advances in Alzheimer's and Parkinson's Therapies, An AAT-AD/PD Focus Meeting in Torino, Italy
SAN FRANCISCO, CA--(Marketwired - February 26, 2018) - Cantabio Pharmaceuticals, Inc. (OTCQB: CTBO), a biopharmaceutical company developing novel disease modifying therapies for Alzheimer's, Parkinson's and other related neurodegenerative diseases, today announced that Dr

Oryzon to present at upcoming international conferences
MADRID, SPAIN and CAMBRIDGE, MA--(Marketwired - April 27, 2018) -

ORYZON Reports Financial Results and Corporate Update for the 4th Quarter and Year Ended December 31, 2017
MADRID, SPAIN and CAMBRIDGE, MA--(Marketwired - February 20, 2018) - Oryzon Genomics, S.A

CTD Holdings Initiates Research Program to Explore Cyclodextrin Therapy for Alzheimer's Disease
ALACHUA, FL--(Marketwired - January 29, 2018) - CTD Holdings, Inc

ORYZON announces First Patient in ORY-2001 MS Phase IIA trial SATEEN and presents new data on ORY-2001 at the third annual ACTRIMS Forum 2018 in San Diego

ORYZON to present at two US investor conferences
MADRID, SPAIN and CAMBRIDGE, MA--(Marketwired - January 23, 2018) -

Cantabio Pharmaceuticals to Present Update from Its DJ-1 Protein Targeting Therapeutic Program for the Treatment of Parkinson's Disease at Advances in Alzheimer's and Parkinson's Therapies, An AAT-AD/PD Focus Meeting in Torino, Italy
SAN FRANCISCO, CA--(Marketwired - January 22, 2018) - Cantabio Pharmaceuticals Inc. (OTCQB: CTBO), a biopharmaceutical company developing novel disease modifying therapies for Alzheimer's, Parkinson's and other related neurodegenerative diseases, today announced that Dr

Take a timeout2vote for Your Favorite NCAA Coach in the INFINITI Coaches' Charity Challenge
NASHVILLE, TN--(Marketwired - January 08, 2018) -

ORYZON to present at the Neuroscience Innovation Forum in San Francisco
MADRID, SPAIN and CAMBRIDGE, MA --(Marketwired - January 04, 2018) - Oryzon Genomics (ISIN Code: ES0167733015) (MAD: ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Dr. Carlos Buesa and Dr

IntelGenx Receives Health Canada Clearance to Begin Phase 2a Study with Montelukast Versafilm(TM) in Mild to Moderate Alzheimer's Disease
IntelGenx Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Company" or "IntelGenx") is pleased to announce that Health Canada has cleared the clinical trial application for its Montelukast VersaFilm™ intended for the treatment of mild to moderate Alzheimer's disease ("AD"). The phase 2a proof of concept ("POC") clinical study will start screening AD patients in Q1 2018.

NobleCon14 - Noble Capital Markets' 14th Annual Institutional Investor Conference / Microcap Showcase Announces Panels -- January, Fort Lauderdale Beach; Research Initiation, Pangaea Logistics (PANL)
FORT LAUDERDALE BEACH, FL--(Marketwired - December 12, 2017) - Noble Capital Markets (Noble) announced today that it has added three panels to the agenda of NobleCon14 to be held at the Four-Diamond oceanfront W Hotel, January 29-30, 2018

Discovery of "Shockingly High" Levels of Aluminum in Brains of Individuals with Autism Suggests Link with Aluminum-Containing Vaccines, says Children's Medical Safety Research Institute
STAFFORDSHIRE, UNITED KINGDOM--(Marketwired - November 30, 2017) - A new study published in the Journal of Trace Elements in Medicine and Biology provides the strongest indication yet that aluminum is an etiological agent in autism spectrum disorder (ASD), announced the Children's Medical Safety Research Institute (CMSRI).

ProBility Media Corp. Enters Into Letter of Intent to Acquire VISYON, a Developer of Virtual & Augmented Reality Applications
ProBility Media Corp. (OTCQB: PBYA), an education and training technology company based in Houston, Texas, today announced the execution of a binding letter of intent to acquire VISYON, based in Barcelona, Spain

Jacobson Pharma Announces FY2018 Interim Results
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company") (HKSE: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its unaudited interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2017 (the "Reporting Period").

PacketFabric Launches PacketDirect for Instantaneous Point-to-Point Networking
PacketFabric, the highly scalable network-as-a-service platform and a member of the NantWorks ecosystem of companies, announces today the immediate availability of PacketDirect, its dedicated point-to-point networking product.

Caring.com awards 28 Holiday Retirement independent senior living communities for service excellence
A senior living choice is not one to be rushed. It is a decision that deserves thoughtful consideration and careful research, which can be made significantly easier thanks to the recent announcement of the "Caring Stars of 2018."

ORYZON to present new preclinical data of ORY-2001 at the Neuroscience 2017 meeting organized by the Society for Neuroscience
MADRID, SPAIN and CAMBRIDGE, MA--(Marketwired - November 13, 2017) -

IntelGenx Submits Montelukast VersaFilm(TM) Clinical Trial Application With Health Canada
IntelGenx Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Company" or "IntelGenx"), today announced that it has submitted a clinical trial application ("CTA") to Health Canada for approval to initiate its Phase 2a proof of concept ("POC") study with Montelukast in mild to moderate Alzheimer's Disease ("AD").

Optium Cyber Systems Announces Creation of Advisory Board
Optium Cyber Systems, Inc. (OTC PINK: OCSY) (the Company) announced today that it has formed an advisory board to oversee and provide objective expertise with the launch of its cyber security monitoring platform in the medical sector. The goal of the Company is to have representation from all aspects of the medical sector including practitioners, management, and IT

ORYZON to participate in three scientific meetings on CNS
MADRID, SPAIN and CAMBRIDGE, MA--(Marketwired - November 02, 2017) -

NetworkNewsWire Announces Publication on Innovative, Cannabis-Based Alzheimer's Treatment Prospects
NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring India Globalization Capital, Inc. (NYSE MKT: IGC), an NNW client positioned as a first mover in developing a portfolio of products using cannabis-based "combination therapies" for the treatment of pain and other conditions.

ORYZON receives approval from AEMPS to start SATEEN: a Phase IIA clinical trial in Multiple Sclerosis with ORY-2001

Streetwise Reports Examines Biotech with Alzheimer's Therapy that Analyst Calls a 'High Risk, High Reward Opportunity'
SAN FRANCISCO, CA--(Marketwired - October 26, 2017) - Mackie Research reported on this company's recent announcement about one of its product candidates targeting Alzheimer's disease.

Future Farm to Acquire a Controlling Interest in Five Dispensaries
Future Farm Technologies Inc. (the "Company" or "Future Farm") (CSE: FFT) (OTCQB: FFRMF) is pleased to announce a new joint venture between Future Farm and TCG Investments, LLC, owners of the Clinica Verde brand of medical cannabis dispensaries ("Clinica Verde"). Future Farm will purchase five pre-qualifications for medical dispensary licenses from Clinica Verde ("Licenses")

Hop-on Subsidiary Re-Medical Turns on CO2 Extraction for THC Cannabis and CBD Hemp in California
Hop-on, Inc. (OTC PINK: HPNN) announced today its subsidiary, Re-Medical, Inc., is now extracting organic flowers of different strains of Medical MMJ and Hemp CBD products in California. No pesticides, Solvent Free, C02 extracted, Pure organic products.

First GREEN Bank Loans $8 Million to CERTUS Senior Living to Construct New Facility in Mount Dora
First GREEN Bank, a local bank with a global mission, today announces an $8 million loan to CERTUS Senior Living, a Central Florida based developer and operator of memory care facilities. CERTUS Senior Living requested the loan to develop CERTUS Premier Memory Care Living, a housing facility designed to accommodate up to 64 residents suffering from Alzheimer's and dementia in Mount Dora.

ORYZON to present new data on its anti-neurodegenerative drug ORY-2001 at the International Conference on Multiple Sclerosis ECTRIMS-ACTRIMS
MADRID, SPAIN and CAMBRIDGE, MA--(Marketwired - October 09, 2017) - Oryzon Genomics (ISIN Code: ES0167733015) (MAD: ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its Chief Scientific Officer, Dr

DesignXcel First Joint-School Design Exhibition in Hong Kong Officially Opened
Organised by The Federation of Hong Kong Industries (FHKI) and its Design Council of Hong Kong (DCHK), the first Joint-School Design Exhibition - DesignXcel has officially opened today (6 October 2017) at Hong Kong Central Library

Stealth Mark Engages Medical Industry Veteran Andrew Stewart
Wellness Center USA, Inc. (OTCQB: WCUI) today announced that its wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, has contractually engaged with Andrew Stewart of Stewart Consulting LLC

3D Signatures Inc. Announces Closing of Second Tranche of Brokered Private Placement
WINNIPEG, MB--(Marketwired - December 22, 2016) -

GIVIT is asking people from all over the country to create and share their own 30 second holiday themed mannequin challenge videos for a chance to win a grand prize of $50,000 to be split evenly between the winner and the charity of their choice; Over $80,000 in total cash prizes are to be awarded
So you and your friends have done the Mannequin challenge video, and it turned out great... BUT what if you could do it for a chance to win $50,000?

ALGAE DYNAMICS CORP Announces New Oil Extraction Initiative Into the Canadian Cannabis Industry
ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company"), a development stage company focused on the commercialization of its proprietary BioSilo® cultivation and extraction system for the growth of algae strains for use in the food and health supplement industry, today announced a new strategic initiative in the extraction of oils from other botanicals, most notably cannabis.

3D Signatures Inc. Announces the Issuance of 5,187,618 Units Pursuant to Its Over-Subscribed $3.9 Million Brokered Private Placement
WINNIPEG, MB--(Marketwired - December 16, 2016) -

Cantabio Pharmaceuticals to Present at the 9th Annual Biotech Showcase in San Francisco
SAN FRANCISCO, CA--(Marketwired - December 15, 2016) - Cantabio Pharmaceuticals, Inc. (OTCQB: CTBO), a biopharmaceutical company developing novel disease modifying therapies for Alzheimer's, Parkinson's and other related neurodegenerative diseases today announced that the company has been selected to present at the 9th Annual Biotech Showcase on January 10th, 2017

Stellar Biotechnologies Reports Fiscal Year 2016 Financial Results
Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines targeting cancers, Alzheimer's and lupus, among other diseases, today reported financial results for the fiscal year ended September 30, 2016 and provided an update on its business.

MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or Refractory CLL or SLL Previously Treated with a BTK Inhibitor
MorphoSys AG /MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or Refractory CLL or SLL Previously Treated with a BTK Inhibitor . Processed and transmitted by Nasdaq Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Stellar Biotechnologies Announces Fiscal Year 2016 Corporate Update Conference Call
Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines targeting cancers, Alzheimer's and lupus, among other diseases, will host a conference call and live webcast on Thursday, December 15, 2016 at 1:30 p.m. ET (10:30 a.m. PT) to discuss its fiscal year 2016 results and to provide an update on its business.

Lyft and CareLinx Partner to Transform Accessibility of Transportation for the Elderly With CareRides
CareLinx Inc., a leading nationwide online caregiver marketplace, specifically focused on helping the elderly and people with disabilities and chronic conditions, today announced a partnership with Lyft, the fastest growing on-demand transportation service in the U.S

3D Signatures Appoints Two Industry Specialists to Board Positions
WINNIPEG, MB--(Marketwired - December 09, 2016) - 3D Signatures Inc. (TSX VENTURE: DXD) (the "Company" or "3DS") is pleased to announce two additional strategic appointments to its Board of Directors and its Clinical and Scientific Advisory Board respectively. Helen Stevenson, Founder and Chief Executive Officer of Reformulary Group Inc., has been appointed to the Company's Board of Directors

Stellar Biotechnologies Appoints Pharma and Capital Markets Experts to Board of Directors
Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines targeting cancers, Alzheimer's and lupus, among other diseases, today announced the appointment of Charles V. Olson, D.Sc. and Paul Chun to the company's Board of Directors.

Plandai Biotechnology, Inc. Announces South African Department of Health Endorses Access to Medicinal Cannabis
Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), producer of the highly bioavailable Phytofare® catechin complex, today announced the Parliamentary Portfolio Committee on Health in South Africa outlined a clear plan endorsing the need for greater availability of medicinal cannabis to those who suffer from chronic pain

Queensland Brain Institute to Accelerate Brain Research with Brocade
Brocade (NASDAQ: BRCD) today announced that The University of Queensland's Queensland Brain Institute will become the first organization in Australia to migrate to Brocade® Gen 6 Fibre Channel storage networking solutions

Milken Institute Center for the Future of Aging Issues "The Power of Purposeful Aging: Culture Change and the New Demography"
LOS ANGELES, CA--(Marketwired - December 07, 2016) - In a report released today, the Milken Institute Center for the Future of Aging explains the many physical and cognitive benefits that older people gain when they provide service to others, and the broad social and economic opportunities that derive from their contributions as they age with purpose

3D Signatures Molecular Imaging Technology Shows Potential in Improving Management of Lung Cancer Patients With Multiple Lesions
WINNIPEG, MB--(Marketwired - December 07, 2016) - 3D Signatures Inc

HealthiNation Announces 2017 Programming Lineup
HealthiNation, a leading provider of mobile videos for health, food and fitness announced its upcoming slate of programming for 2017, expanding its leadership in high quality, medically accredited (URAC) video programming focused on health conditions. HealthiNation videos are available to viewers on HealthiNation.com and all its social platforms.

The Arbor Company Publishes Holiday Guide
ATLANTA, GA--(Marketwired - December 06, 2016) - The Arbor Company, a premier operator of senior living communities, today announced it is publishing a guide for families planning on celebrating the holidays with senior loved ones. The e-book, Home for the Holidays, is available for free download at https://www.arborcompany.com/guide-home-for-the-holidays.

The Life Sciences Report Examines How Disruptive Biotech and Technology Platform Sets Up 3D Signatures for Explosive Growth
SAN FRANCISCO, CA--(Marketwired - December 15, 2016) - 3D Signatures Inc. (TSX VENTURE: DXD), a Canadian company developing a platform of "disruptive" personalized prognostic tests for patients with 13 different cancers and Alzheimer's disease, has attracted the attention of several stock watchers with its most recent announcements.

StockNewsNow.com Publishes New SNNLive Video Interview With BioLargo, Inc.
LOS ANGELES, CA--(Marketwired - December 23, 2015) - StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Dennis Calvert, President and CEO of BioLargo, Inc

Oxton Senior Living Announces the Acquisition of Senior Living Community in Opelika, Alabama
OPELIKA, AL--(Marketwired - December 01, 2015) - Oxton Senior Living, a leading provider of outstanding personal care, assisted living and memory care communities in Georgia and Alabama, announced the acquisition of Cambridge Place in Opelika, Alabama at 1001 Fox Run Parkway. The new name of the senior living community is now Oxton Court at Opelika

MBHC Finalizes Acquisition and Names New President Experienced in Cannabis Industry
Mobile Broadcasting Holding, Inc. (OTC PINK: MBHC) announces that it has completed acquisition of Medically Minded, LLC, a company focused on providing medical cannabis, medical cannabis-related products, and medical tourist services. In a move to quickly organize its operations, the Company has installed its new president, Ken Sobel. As a consequence of this move, Stephen A

The tranSMART Foundation Expands, Assuming Responsibility of the OpenBEL Project From Selventa
The tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share pre-competitive translational research data, today announced that it will manage and further develop the OpenBEL project in an agreement with Selventa

Alzheimer's Foundation of America Statement

After Successful Formulation Work, Cannabis Science Follows Through With a Full Clinical Drug Development Agreement With ImmunoClin to Deliver GMP Quality Pre-Clinical Data to Enter CS-NEURO-1 Into a Phase I Human Study in Europe
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced that it has entered into a comprehensive clinical drug development to focus on delivering GMP quality pre-clinical data to enable entry of CS-NEURO-1 into a Phase I human study in Europe with ImmunoClin (OTCQB: IMCL).

Stellar Biotechnologies Reports Fiscal Year-End 2015 Financial Results and Operational Highlights
Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), reported financial results for the year ended September 30, 2015.

Stellar Biotechnologies Announces Year-End 2015 Corporate Update Conference Call
Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), will host its year-end 2015 corporate update conference call and live webcast on Tuesday, December 15, 2015 at 1:30 PM ET (10:30 AM PT).

Dementia Care Professionals of America Names 2015 Dementia Care Professional of the Year
NEW YORK, NY--(Marketwired - December 09, 2015) - Teryn Clarke, M.D., medical director of Alzheimer's Family Services Center in Huntington Beach, Calif., and board-certified neurologist at Hoag Neurosciences Institute in Newport Beach, Calif., has been named Dementia Care Professionals of America's (DCPA) Dementia Care Professional of the Year

Money Matters
(Family Features) If you've been entrusted to assist an elderly relative with scheduling preventive exams and putting a health care plan in place, you may struggle with knowing when it's time to take on a greater role in other aspects of their life. That's why now is the perfect time to look for warning signs that your loved ones might be suffering from a decline in financial ability.

Inspire Launches Redesigned Online Health Community to Improve Patient and Caregiver Experience
PRINCETON, NJ--(Marketwired - December 07, 2015) - Inspire, the largest social network for patients and caregivers, has released an upgraded design that enables patients to better engage with and navigate the site, and meets the needs of the growing group of mobile healthcare consumers.

New Clinical Data on MorphoSys's Blood Cancer Drug Candidate MOR208 in NHL and CLL Presented at ASH Annual Meeting
MorphoSys AG /New Clinical Data on MorphoSys's Blood Cancer Drug Candidate MOR208 in NHL and CLL Presented at ASH Annual Meeting . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

MorphoSys Presents Interim Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple Myeloma at ASH Meeting
MorphoSys AG /MorphoSys Presents Interim Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple Myeloma at ASH Meeting . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Stellar Biotechnologies Presents Preclinical Poster on Clostridium Difficile Research at Society for Glycobiology Meeting
Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT) (TSX VENTURE: KLH), announced today the presentation of a preclinical poster relating to its research on Clostridium difficile ("C. difficile"), at the Society for Glycobiology 2015 Annual Meeting, in San Francisco, California, December 1-4, 2015.

SENS Research Foundation Raises Over $27,000 on #GivingTuesday
MOUNTAIN VIEW, CA--(Marketwired - December 03, 2015) - The SENS Research Foundation (SRF), a non-profit organization focused on transforming the way the world researches and treats age-related disease, received $27,317 on December 1, #GivingTuesday -- more than double what the foundation raised on #GivingTuesday 2014

Antis Roofing Earns Bronze Best in Biz Award
Antis Roofing & Waterproofing -- one of Southern California's most trusted names in the roofing and decking industry -- has been awarded a bronze Best in Biz award in the Most Socially Responsible Company of the Year category

Iris BioTechnologies Inc. Reports on Legal Proceedings Involving Heller Ehrman LLP
SANTA CLARA, CA--(Marketwired - November 25, 2015) - On November 20, 2015, the Ninth Circuit Court of Appeals affirmed the lower court decision denying Iris's motion to file a malpractice claim against its former legal counsel Heller Ehrman LLP. Heller Ehrman was a reputable, one-hundred-plus-years-old law firm with more than 600 attorneys

SENS Research Foundation Joins the Global #GivingTuesday Movement
The SENS Research Foundation (SRF), a non-profit organization focused on transforming the way the world researches and treats age-related disease, has joined #GivingTuesday, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and celebrate generosity worldwide

Stellar Biotechnologies to Present at LD Micro Main Event
Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (NASDAQ: SBOT) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), today announced that Frank Oakes, President and Chief Executive Officer of Stellar, will present at the LD Micro Main Event, to be held December 1-3, 2015 in Los Angeles, CA.

GTX Corp (GTXO) CEO Featured in Exclusive QualityStocks Interview
QualityStocks today announces the availability of a new audio interview with Patrick Bertagna, CEO of GTX Corp (OTCQB: GTXO), an IoT platform and leading provider of personal location GPS wearable technology and wandering assistive technology. The interview can be heard at http://www.QualityStocks.net/interview-gtxo.php.

South Dakota Based Mitogenetics Revolutionizes How People Manage Diseases
Mitogenetics, a biomedical technology firm with strong South Dakota roots, in partnership with the State University of New York, is developing technology to regulate the action of mitochondria

Mitogenetics Revolutionizes How People Manage Diseases
Mitogenetics, a biomedical technology firm in partnership with the State University of New York, is developing technology to regulate the action of mitochondria

Stevia Corp. Confirms Protocol to Produce Synthetic CBD
Stevia Corp

MorphoSys AG: Corporate Calendar 2015
MorphoSys AG /MorphoSys AG: Corporate Calendar 2015. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

MorphoSys Announces Clinical Milestone in Oncology Program
MorphoSys AG /MorphoSys Announces Clinical Milestone in Oncology Program. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

MorphoSys's Partner Roche Provides Update on Trial of Gantenerumab in Prodromal Alzheimer's Patients
MorphoSys AG /MorphoSys's Partner Roche Provides Update on Trial of Gantenerumab in Prodromal Alzheimer's Patients . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Cornerstone Healthcare Group Announces Agreement to Acquire TrinityCare Senior Living
Cornerstone Healthcare Group ("Cornerstone" or "CHG"), a private company owned by funds managed by Highland Capital Management, L.P., today announced the company has entered into an agreement to acquire the operations of TrinityCare Senior Living ("TrinityCare") for cash and assumed debt of $27 million. A subsidiary of University General Health System, Inc

MorphoSys's MOR208 Program Receives Positive Opinion for Orphan Medicinal Product Designation from EMA for DLBCL
MorphoSys AG /MorphoSys's MOR208 Program Receives Positive Opinion for Orphan Medicinal Product Designation from EMA for DLBCL . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Alzheimer's Foundation of America Statement on Proposed $25 Million Increase for Alzheimer's Disease in FY'15 Federal Budget

Alzheimer's Foundation of America Names 2014 Dementia Care Professionals of the Year
NEW YORK, NY--(Marketwired - December 09, 2014) - The Alzheimer's Foundation of America's (AFA) Dementia Care Professionals of America (DCPA) division today announced two "Dementia Care Professionals of the Year" for 2014. This marks the first time two individuals have been awarded this distinction. Lorenzo Mejia, president of Acorn Home Care in Carrboro, N.C., and Dr

MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at American Society of Hematology Meeting
MorphoSys AG /MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at American Society of Hematology Meeting . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting
MorphoSys AG /MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Piramal Imaging Taps M2i to Manufacture and Distribute NeuraCeq(TM) in Ireland
Piramal Imaging today announced it has entered into a definitive agreement with M2i for the exclusive manufacturing and distribution of NeuraCeq in Ireland. With this agreement M2i through their Dublin PET manufacturing site, aims to bring NeuraCeq to market as the first locally manufactured beta-amyloid tracer in the Republic of Ireland and Northern Ireland.

Koss Corporation Partners With Music & Memory to Provide iPods and Headphones to Alzheimer Patients During #GivingTuesday
Koss® Corporation (NASDAQ: KOSS), the U.S. based high-fidelity Stereophone manufacturer and inventor of the world's first SP3 Stereophone in 1958, announced a #GivingTuesday fundraising partnership with MUSIC & MEMORY.

Grupo Gallegos Named Best Independent US Hispanic Agency at El Ojo Awards
Grupo Gallegos, a creatively-driven independent advertising agency, was recognized as the Best Independent US Hispanic Agency at the 2014 El Ojo de Iberoamérica festival of creativity. The festival, held November 19-21st in Buenos Aires, Argentina, celebrates the best in advertising in the Spanish and Portuguese-speaking world

Stellar Biotechnologies to Present at LD Micro Conference
Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today the Company's management team will present at the upcoming LD Micro Conference on Tuesday, December 2 at 1:00 p.m. PST.

UPDATE - Grupo Gallegos, Alzheimer's Association Launch "The Unforgettable Collection" Awareness Campaign
This week Grupo Gallegos, a creatively driven, independent advertising agency, and the Alzheimer's Association California Southland Chapter will launch the first photo collection dedicated to the fight against Alzheimer's -- a disease that affects more than 5 million Americans

Ossianix Expands and Extends Its Research Collaboration with Lundbeck on CNS Therapeutics
Ossianix, Inc. has announced an expansion and extension of its strategic research collaboration with H. Lundbeck A/S (Lundbeck). This collaboration follows a previous equity investment in 2012 and prior research collaboration in 2013

Otsuka Pharmaceutical to Acquire Avanir Pharmaceuticals
Otsuka Pharmaceutical Co., Ltd. is pleased to announce an agreement with Avanir Pharmaceuticals, Inc. (“Avanir”) in which Otsuka America, Inc., a US subsidiary, acquires Avanir for USD 3.5 billion in an all-cash tender offer. The contract was signed on December 2, Japan time.

Global Survey Finds That Pancreatic Cancer, a Leading Cause of Cancer Deaths, is Virtually Unknown by Many in Europe and US
While it may not be surprising that breast and lung cancers are top of mind when people hear the word “cancer,” 60% of respondents to a recent six-country survey about cancer awareness know almost nothing about pancreatic cancer, a leading cancer killer

US Equity Holdings CEO Joins Buck Advisory Council
Chester Aldridge, Chairman and CEO of US Equity Holdings, has joined the Buck Institute's Buck Advisory Council (BAC). The long-time Marin resident will take an active role in advising the Institute on the commercialization of some of its most promising research assets

Orion Corporation signs license agreement with Janssen Pharmaceuticals, Inc. for the development and commercialization of its novel treatment for Alzheimer's disease
    ORION CORPORATIONSTOCK EXCHANGE RELEASE 19 DECEMBER 2013 at 7.45 p.m. EET    

FluoroPharma Medical Announces Acceptance of Abstract for Oral Presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Winter Meeting
MONTCLAIR, NJ--(Marketwired - December 19, 2013) - FluoroPharma Medical, Inc

Ben Franklin to Invest $342,378 in Regional Economic Development
The Ben Franklin Technology Partners of Northeastern Pennsylvania (BFTP/NEP) board approved the investment of $342,378 in regional companies. BFTP/NEP is an award-winning, state-funded economic development organization that links early-stage technology firms and established manufacturers with experts, universities, funding, and other resources to help them prosper through innovation

MorphoSys Strengthens Clinical Development Organization with Three Management Appointments
MorphoSys AG /MorphoSys Strengthens Clinical Development Organization with Three Management Appointments . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Alzheimer's Foundation of America Offers Tips to Keep the Cheer in the Holidays

Alzheimer's Foundation of America Introduces Two Caregiver-Focused Chats
NEW YORK, NY--(Marketwired - December 16, 2013) - In an effort to help increase real-time feedback and resources for caregivers of individuals with Alzheimer's disease and related illnesses, the Alzheimer's Foundation of America (AFA) today announced two new series of online chats featuring medical and caregiving experts. Both chats will be hosted via AFA's Twitter account @alzfdn.

Premier Biomedical Secures $5 Million Equity Funding From Kodiak Capital Group, LLC
Premier Biomedical, Inc

Alzheimer's Foundation of America Releases 'A Roadmap to Alzheimer's Disease & Driving' DVD
NEW YORK, NY--(Marketwired - December 12, 2013) - "Taking away the keys" often is one of the most difficult decisions family and professional caregivers of individuals with Alzheimer's disease and related illnesses face as symptoms progress to the point that drivers with the brain disorder pose a potential danger on the road -- to themselves and others

Plandai Biotechnology's CEO Discusses Direction of Medical Marijuana Subsidiary
Plandaí Biotechnology's (OTCQB: PLPL) subsidiary, Cannabis Biosciences, Inc., will be developing and testing a botanical extract derived from cannabis, and the company's CEO, Roger Duffield, announced it will address neural disorders with its marijuana research

Intelligent Living Inc. (ILIV) to Go Head-to-Head With Lumosity in the $6.6 Billion Brain Fitness Arena
Intelligent Living Inc. (OTCQB: ILIV) announced today that the MIND360 brain games platform is out of beta and has been launched on www.mind360games.com. The MIND360 platform consists of game-like exercises designed to train and improve cognitive functions. The programs target different parts of the brain, and are experimentally tested with the help of collaborators at top academic institutions

CareFamily Provides Help at Home for the 5.2 Million Americans Dealing With Dementia and Alzheimer's
CareFamily, a pioneer in online caregiver matching and self-directed home care for seniors, today announced help for families and caregivers working with individuals with dementia and its most common form, Alzheimer's disease

MorphoSys Announces Additional Clinical Trial of MOR208
MorphoSys AG /MorphoSys Announces Additional Clinical Trial of MOR208. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Taconic and Oligomerix to Collaborate on Tau Mouse Model Characterization for Use in Alzheimer's Disease Research
Taconic and Oligomerix, Inc. announced a collaboration to evaluate the utility of the Taconic tau mouse model (also known as the JNPL3 mouse) as a tool for pre-clinical testing of compounds for Alzheimer's disease

Plandai Biotechnology, Inc. to Focus Marijuana Research on Neuron Disorders Including Alzheimer's, Parkinson's, and Multiple Sclerosis
Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today released a statement from company Chairman and Chief Executive Officer, Roger Duffield, in which the company addressed progress with its recently announced subsidiary, Cannabis Biosciences, Inc

Latteno's Co-Op Valley Organics Introduces New Medical Cannabis Products
Latteno Food Corp.'s (OTC Pink: LATF) wholly-owned subsidiary Co-op Valley Organics, today announced CBD-100, a 100% Organics, 100% Natural Hemp Oil for Medical Cannabis patients. This is an exclusive right to market and distribute with defined term and conditions. Our CBD-100 is made from Canadian Industrial Hemp NOT from Marijuana

Alzheimer's Foundation of America and Second Wind Dreams Team Up to Help Fulfill Dreams for People With Dementia
NEW YORK, NY--(Marketwired - December 05, 2013) - As people across the country are finalizing their holiday wish lists, the Alzheimer's Foundation of America (AFA) and Second Wind Dreams (SWD) are teaming up to help make the dreams of people with Alzheimer's disease or related illnesses a reality

Philanthropedia Identifies Highest-Performing Nonprofits in Two Cause Areas: People With Disabilities (National); and Climate Change (Bay Area)
WASHINGTON, DC--(Marketwired - December 05, 2013) - Philanthropedia, a division of leading nonprofit information provider GuideStar, today announced new rankings of the top 16 nonprofits supporting people with disabilities nationally and the top 18 nonprofits working on climate change in the San Francisco Bay Area

Confirmatory Testing Affirms Prevention of Metastasis in Premier Biomedical Candidate Therapy for Breast Cancer
Premier Biomedical, Inc

MorphoSys Strengthens European Patent Position on anti-CD19 Cancer Program MOR208
MorphoSys AG /MorphoSys Strengthens European Patent Position on anti-CD19 Cancer Program MOR208 . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Q Therapeutics' Collaborators at Johns Hopkins Are Awarded Funding From National Institutes of Health
Q Therapeutics, Inc. today announced that its collaborators at The Johns Hopkins University have been awarded $1.3 million in a third year of grant funding from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)

Biotie reports top-line data from clinical study with nepicastat (SYN117) in post-traumatic stress disorder
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 27 December 2012 at 9:00 a.m

Q Therapeutics Issues Formal Update on Key Corporate and Operational Developments
Deborah Eppstein, PhD, President and CEO of Q Therapeutics, Inc., an emerging biotechnology company utilizing its proprietary innovative technology to develop breakthrough cell therapy products for the treatment of debilitating diseases of the central nervous system, today issued a formal update in the form of a CEO letter posted to the Company's web site at www.qthera.com.

MorphoSys to Host Conference Call on Bio-Rad's planned Acquisition of MorphoSys's Research and Diagnostic Antibody Business AbD Serotec
MorphoSys AG /MorphoSys to Host Conference Call on Bio-Rad's planned Acquisition ofMorphoSys's Research and Diagnostic Antibody Business AbD Serotec.

MorphoSys to Host Conference Call on Bio-Rad's planned Acquisition of MorphoSys's Research and Diagnostic Antibody Business AbD Serotec
MorphoSys AG /MorphoSys to Host Conference Call on Bio-Rad's planned Acquisition of MorphoSys's Research and Diagnostic Antibody Business AbD Serotec . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Bio-Rad to Acquire MorphoSys's Research and Diagnostic Antibody Business AbD Serotec
MorphoSys AG /Bio-Rad to Acquire MorphoSys's Research and Diagnostic Antibody BusinessAbDSerotec. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement

Bio-Rad to Acquire MorphoSys's Research and Diagnostic Antibody Business AbD Serotec
MorphoSys AG /Bio-Rad to Acquire MorphoSys's Research and Diagnostic Antibody Business AbD Serotec . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Biotie: Selincro(TM) (nalmefene) receives positive opinion for approval in the European Union
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 14 December 2012 at 14:10

Biotie's tozadenant (SYN115) meets primary and multiple secondary endpoints in phase 2b study in Parkinson's disease
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE  11 DECEMBER 2012 at 9:00 a.m.

MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202
MorphoSys AG /MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Charityshare Selects Violin Memory and Capita IT Services Business for Flash Memory VDI Solution
Violin Memory, Inc

MorphoSys to Present at an Upcoming Investor Conference
MorphoSys AG / MorphoSys to Present at an Upcoming Investor Conference.Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement

Q Therapeutics Announces U.S. and Canadian Patent Awards
Q Holdings, Inc., dba Q Therapeutics, Inc., an emerging biotechnology company utilizing its proprietary innovative technology to develop breakthrough cell therapy products for the treatment of debilitating diseases of the central nervous system, today announced the issuance of United States Patent No

Connectyx Technologies Joins Seniors-Helping-Seniors in Pilot Program to Distribute MedFlash and GuardianOne
Connectyx Technologies Holdings Group, Inc.(PINKSHEETS: CTYX), www.connectyx.com, a Healthcare Business Process Outsourcing (BPO) company with personal healthcare product offerings, announced today that Seniors-Helping-Seniors is initiating a pilot program offering MedFlash and Medical Alert US (or GuardianOne) to its thousands of senior Florida customers.

MorphoSys and Lanthio Pharma Sign Technology Alliance on New Class of Therapeutic Peptides
MorphoSys AG /MorphoSys and Lanthio Pharma Sign Technology Alliance on New Class ofTherapeutic Peptides. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

ProTrials Adds Diane Wong as Director of Quality Assurance
ProTrials Research™, Inc., a leader in the clinical research organization (CRO) industry, has added industry veteran Diane Wong to its senior staff as director of quality assurance

FluoroPharma Medical, Inc. Announces $1.5M Equity Financing
FluoroPharma Medical, Inc

Alzheimer's Research Forum Story Highlights ERPs as Biomarker of Interest
Reporting on the recent Clinical Trials on Alzheimer's Disease (CTAD) conference held in Monte Carlo, Alzheimer's Research Forum (www.alzforum.org) reported a pressing need for biomarkers as outcome measures in Alzheimer's drug trials, and a heightened interest in electroencephalography (EEG) and event-related potentials (ERPs)

Alzheimer's Caregivers Can Fight the Disease
(Family Features) Caring for someone with Alzheimer's disease is challenging under the best of circumstances. Across the United States, more than five million people ages 65 and older are currently living with Alzheimer's disease (AD). And over 15 million more Americans -- family members, friends, neighbors and volunteers -- provide unpaid care for a loved one with AD.

New Quintiles Resource for Cancer Patients Wins Third Health Award for ClinicalResearch.com
Cancer patients looking for clinical trials of oncology therapies in their own areas plus information and news to help them understand the disease and its treatments have a valuable new online resource at www.ClinicalResearch.com. The Quintiles-created site has now been recognized with its third Web Health Award in as many years.

Diet rich in vitamins and fish oils could prevent Alzheimer's
People taking diets high in several key vitamins or in health-boosting omega-3 fatty acids are less likely to develop the brain shrinkage linked to Alzheimer's disease, according to a new research.

Diet rich in vitamins and fish oils helps keep elderly brains healthy
Elderly people with higher levels of several vitamins and omega 3 fatty acids in their blood have better performance on mental acuity tests and less of the brain shrinkage typical of Alzheimer's disease, according to a new study.

Multi-vitamin supplements 'do nothing for our health'
Experts have said that millions of consumers might be wasting their money on multi-vitamin supplements, as they do nothing for health.

Lingonberries can protect blood vessels of BP and diabetic patients
Ligonberry has a much higher antioxidant level in certain capacities than blueberries or raspberries, and it can help protect blood vessels of people who have hypertension or have diabetic damage from too much blood sugar, a Finland researcher has claimed.

Silent strokes or dead brain cells behind memory loss in elders
A new study has suggested that 'silent strokes,' or small spots of dead brain cells, found in about one out of four older adults may have lead to memory loss in the elderly.

Early detection may delay Alzheimer's development among patients
A researcher has found a new way to approach early detection of Alzheimer's disease.

Smaller brain size may signal Alzheimer's
People with smaller regions of the brain's cortex may be more likely to develop symptoms consistent with very early Alzheimer's disease, a new study has suggested.

Cerebrospinal fluid test can detect Alzheimer's at early stage
Researchers have revealed that analysis of the cerebrospinal fluid (CSF) can detect whether a person has Alzheimer's disease before symptoms appear.

Biotie's partner Lundbeck submits European Marketing Authorization Application for Selincro(TM) (nalmefene)
BIOTIE THERAPIES CORP.  STOCK EXCHANGE RELEASE 21 December  2011 at 9.30 a.m.  

ProteoTech Announces Drug Development Collaborative Agreement with GlaxoSmithKline for New Parkinson’s Therapeutic
ProteoTech, Inc

Comment on this story

Share